Question · Q3 2025
Susan Anderson asked about the efficiencies and potential margin impact resulting from the further integration of Hiya Health into USANA's operations, broader industry trends concerning VMS/wellness purchases and consumer value-seeking, and the company's future diversification strategy, including potential DTC business acquisitions.
Answer
Chief Operating Officer Walter Noot detailed plans for USANA to manufacture all of Hiya Health's vitamins in-house and noted cost reductions from assisting Hiya Health in transitioning to a new 3PL partner, with more quantitative details expected in February. CEO Jim Brown acknowledged a general struggle in direct selling post-COVID but highlighted strong performance from Hiya Health and RiseBar, emphasizing USANA's high-quality, differentiated products. Jim also confirmed diversification as a core strategy, seeking M&A opportunities, with CFO Doug Hekking prioritizing investments in commercial strategy and venture companies.